957198-30-0 Usage
General Description
The chemical 2-(4-morpholino)pyrimidine-5-boronic acid pinacol ester is an organic compound that contains a boronic acid functional group. It is commonly used in organic synthesis as a reagent for the formation of carbon-carbon and carbon-heteroatom bonds, particularly in the field of medicinal chemistry. 2-(4-MORPHOLINO)PYRIMIDINE-5-BORONIC ACID PINACOL ESTER is often employed in the synthesis of pharmaceuticals and agrochemicals, as well as in the development of new materials. It can also serve as a building block for the preparation of various heterocyclic compounds. Due to its versatile reactivity and potential applications, 2-(4-morpholino)pyrimidine-5-boronic acid pinacol ester is a valuable compound in the field of organic and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 957198-30-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,7,1,9 and 8 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 957198-30:
(8*9)+(7*5)+(6*7)+(5*1)+(4*9)+(3*8)+(2*3)+(1*0)=220
220 % 10 = 0
So 957198-30-0 is a valid CAS Registry Number.
957198-30-0Relevant articles and documents
1,5,7-TRISUBSTITUTED ISOQUINOLINE DERIVATIVES, PREPARATION THEREOF, AND USE THEREOF IN MEDICINES
-
Paragraph 0230; 0232; 0234, (2020/08/30)
The present disclosure relates to 1,5,7-trisubstituted isoquinoline derivatives, their preparation and pharmaceutical use. In particular, the present disclosure discloses a compound of formula (I) or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, and a preparation method and use thereof. The definitions of the groups in the formula can be found in the specification and claims.
HETEROARYL COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF
-
Paragraph 00730, (2016/01/25)
The present invention provides herein is a heteroaryl compound or a stereoisomer, a geometric isomer, a tautomer, a racemate, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, as well as a pharmaceutical composition containing the compound disclosed herein. The present invention also provides herein is use of the compound or the pharmaceutical composition thereof disclosed herein in the manufacture of a medicine for treating autoimmune diseases or proliferative diseases.